Personal tools

FF:0000625: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
 
Line 12: Line 12:
|is_obsolete=
|is_obsolete=
|located_in=
|located_in=
|name=experimental infection
|name=experimental infection sample
|namespace=FANTOM5
|namespace=FANTOM5
|obo_creation_date=2011-08-29T11:23:40Z
|obo_creation_date=2011-08-29T11:23:40Z

Latest revision as of 16:57, 12 September 2014

outline

  • id: FF:0000625
  • name: experimental infection sample
  • namespace: FANTOM5
  • def: "A treatment whereinfectious agents, or compunds derived frmo infectious agents, are administered." [GOC:tfm]
  • created_by: tmeehan
  • creation_date: 29 August 2011 11:23:40
  • CAGEd oPOSSUM: NA

Ontology association

Parents

is_a:EFO:0000727(treatment)

Children

is a:FF:0000335 (LPS treatment sample),FF:0000628 (Bacillus Calmette-Guerin treatment sample),FF:0000630 (beta-glucan treatment sample),FF:0000631 (trehalose dimycolate (TDM) treatment sample),FF:0000632 (group A streptococci treatment sample),FF:0000633 (Salmonella treatment sample),FF:0000634 (Cryptococcus treatment sample),FF:0000635 (Candida treatment sample),FF:0000647 (udorn influenza infection sample),FF:0000648 (mock infection sample),FF:10452-106G2 (cord blood derived cell line:COBL-a 24h infection(-C)),FF:10453-106G3 (cord blood derived cell line:COBL-a 24h infection)

FF Samples

Human

  • 10452-106G2 (cord blood derived cell line:COBL-a 24h infection(-C))
  • 10453-106G3 (cord blood derived cell line:COBL-a 24h infection)